Ibatron Tablet 150mg (Ibandronic Acid Sodium Monohydrate)

Adult dose

Take 1 tablet regularly once a month on the same day in the morning at least 1 hour before ingesting food, beverages (except water), or other oral medications or dietary supplements (including calcium). This medication should be swallowed with an adequate amount of water (180-240ml) while in a standing or seated position, and patients must not lie down for 60 minutes after taking it. Mineral water can reduce the absorption of this medication.

Child dose

Efficacy and safety in children under 18 years of age have not been studied.

This medication should not be used by certain patients. For example, those allergic to this medicine or its components, untreated hypocalcemia patients, those who cannot sit or stand upright for more than 60 minutes, patients with esophageal function issues that hinder swallowing, and individuals with lactose intolerance or genetic metabolic disorders should not take this medication. Patients with severe renal impairment should be particularly cautious when using this medication. If kidney function is significantly diminished, the effects of the drug may vary. While taking this medication, mild to moderate side effects such as dyspepsia, nausea, abdominal pain, diarrhea, headache, myalgia, arthralgia, and rash may occur. Most of these symptoms are mild to moderate and often do not require discontinuation of treatment. In rare cases, patients may experience symptoms such as esophagitis, esophageal ulcers, dysphagia, dizziness, back pain, angioedema, or urticaria, in which case they should consult a medical professional. This medication may irritate the esophagus and gastric mucosa, thus it is important to remain upright for at least 60 minutes after taking it and not to take it with food or other medications. Additionally, calcium and vitamin D levels should be adequately managed prior to using this medication, and it should be taken at an interval from any drugs that may interfere with absorption, such as calcium, antacids, or iron supplements. Severe side effects such as osteonecrosis of the jaw have been reported, so it is recommended to consult with healthcare providers before undergoing dental treatment and to avoid excessive dental procedures during treatment. It is advised not to use this medication during pregnancy or breastfeeding. Safety in children and adolescents under 18 years of age has not been established. In cases of overdose, gastrointestinal disturbances or hypocalcemia may occur, and vomiting should not be induced; the patient should be kept sitting or standing. This medication should be kept out of reach of children, and expired medicines should be disposed of properly to avoid environmental harm.

Serious side effects

Urticaria, severe swelling (angioedema, facial swelling), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, difficulty or trouble breathing, asthma attacks, cough with fever accompanied breathing abnormalities, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances

Mild side effects

• Dyspepsia
• nausea
• abdominal pain
• diarrhea
• bloating
• gastroesophageal reflux disease
• headache
• influenza-like illness
• fatigue
• myalgia

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should ideally be room temperature between 1°C and 30°C. This ensures the medication's efficacy is maintained for a longer period.

Appearance

White to almost white rectangular film-coated tablet

Package unit

1 tablet/PTP